Wyoming prescription drug transparency act.

Wyoming's SF 151, the Prescription Drug Transparency Act, prohibits pharmacy benefit managers (PBMs) from engaging in specific practices that affect independent pharmacies and patients. It bans PBMs from charging pharmacies fees for basic services (like claim submissions or network enrollment), retroactively reducing payments without fraud/audit justification, restricting patient choice of in-network pharmacies, or using "spread pricing" (charging plans more than paid to pharmacies). The bill requires PBMs to reimburse independent pharmacies at the same rate paid to PBM-owned pharmacies, allow electronic batch appeals, and provide transparent contract information. These changes directly impact pharmacies, PBMs, and patients by increasing pricing transparency and reducing financial barriers for community pharmacies.